Companies: 10,795·Total market cap: $144.5T
BioNTech SE

BioNTech SE

BNTXNASDAQHealthcare● Active
$88.08
$-1.51(-1.69%)
Market Cap$22.3B
P/E Ratio
52W High$124
52W Low$79.52
Overview

BioNTech SE (BNTX) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

bntx · stock forecast · 24 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 24 Wall Street analysts in the past 3 months

SellBuy

Buy

24 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
21
Hold
3
Sell
0
Strong Sell
0
Total: 24 · Buy rate: 87.5%

12-Month Price Target

High

$158

Consensus

$135

+53.4% upside

Low

$96.00

Median: $138 · Last Close: $88.08

The BioNTech SE (BNTX) analyst consensus is Buy, based on ratings from 24 Wall Street analysts over the past 3 months. The average 12-month BNTX price target is $135.09, representing +53.4% upside from the current price of $88.08.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $135 (53.4%)

Consensus Target

$135.09

53.4% upside

High Target

$158

79.4%

Low Target

$96

9.0%

Current Price

$88.08

as of today

Based on analyst price targets, the BNTX stock price prediction for the next 12 months ranges from $96 to $158. The consensus BNTX price forecast of $135.09 implies 53.4% upside from the current price of $88.08.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$86.811.44%

1-day model range: $86.47–$87.15. Peak: $87.15 (-1.44%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$70-20.3%
2028$61-30.9%
2029$56-36.8%
2030$53-40.3%
2031-42.5%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

0%7%93%
0Buy
1Neutral
13Sell
RSI (14)46.3Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · BNTX · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$89.39SELL
MA 10$91.37SELL
MA 20$91.33SELL
MA 50$94.81SELL
MA 100$99.69SELL
MA 200$100.29SELL
Current $BNTX · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$89.54SELL
EMA 10$90.53SELL
EMA 20$91.94SELL
EMA 50$94.56SELL
EMA 100$97.04SELL
EMA 200$99.64SELL
Current $BNTX · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
UBS2026-05-27
Upgrade ↑
NeutralBuy
Wells Fargo2026-05-06
Maintains
OverweightOverweight
Canaccord Genuity2026-05-06
Maintains
BuyBuy
HC Wainwright & Co.2026-04-27
Maintains
BuyBuy
Morgan Stanley2026-04-10
Maintains
OverweightOverweight
HC Wainwright & Co.2026-03-31
Maintains
BuyBuy
Citigroup2026-03-11
Maintains
BuyBuy
Morgan Stanley2026-03-11
Maintains
OverweightOverweight
TD Cowen2026-03-11
Maintains
HoldHold
Canaccord Genuity2026-03-11
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on BioNTech SE (BNTX) stock. Of the recent 199 rating actions, 16 were upgrades and 10 were downgrades. 24 analysts currently cover BNTX.

Analyst Recommendation Trends

Buy ratings13↑ +2
Hold ratings101
Sell ratings00

BNTX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 3 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$2.2B

↓ 18.0% YoY

Revenue Next Year

$2.2B

↑ 3.0% YoY

EPS This Year

$-4.62

EPS Next Year

$-4.83

↑ 4.4% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast BNTX EPS of $-4.62 for the current fiscal year, based on estimates from 10 analysts. The BNTX revenue forecast is $2.2B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The BNTX stock forecast is supported by two independent data sources: analyst consensus ratings from 24 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BNTX price target is $135.09 (+53.4% upside), with an analyst consensus of Buy.

The BNTX short-term stock prediction for tomorrow is $86.81 (-1.44%). The BNTX stock price prediction for 2027 estimates an average of $70. The BNTX stock prediction for 2030 projects a range of $50–$55.

BioNTech SE trades on NASDAQ under the ticker BNTX. The BNTX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 88% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

BNTX forecast · 8 questions

According to 24 Wall Street analysts, the average 12-month BNTX price target is $135.09, with a high forecast of $158.00 and a low of $96.00. The median price target is shown in the chart above when available. This implies +53.4% potential upside from the current price of $88.08.

BNTX price targetWhat is BNTX price targetBNTX analyst price targetBNTX 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.